Cannabidiol shows promise alongside conventional epilepsy medication in Lennox-Gastaut Syndrome
The use of medical cannabis to treat seizures has been in the news a lot this week due to the…
ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study
ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor’s…
CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical Company for Pediatric Rare Disease Phase II Study
CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has been…